FDA Approves Juxtapid for Homozygous Familial Hypercholesterolemia
12.21.2012 | No Comments ››On Dec. 21, the U.S. Food and Drug Administration approved Juxtapid (lomitapide) to reduce low-density lipoprotein (LDL) cholesterol, total cholesterol, apolipoprotein B, and non-high-density lipoprotein ... Continue Reading ››
FDA Approves Varizig for Reducing Chickenpox Symptoms
12.21.2012 | No Comments ››The U.S. Food and Drug Administration has approved Varizig for reducing the severity of chicken pox (varicella zoster virus) infections in high risk individuals when ... Continue Reading ››
FDA Expands Tamiflu’s Use to Treat Children Younger than 1 Year
12.21.2012 | No Comments ››The U.S. Food and Drug Administration today expanded the approved use of Tamiflu (oseltamivir) to treat children as young as 2 weeks old who have ... Continue Reading ››
FDA Approves Gattex to Treat Short Bowel Syndrome
12.21.2012 | No Comments ››The U.S. Food and Drug Administration today approved Gattex (teduglutide) to treat adults with short bowel syndrome (SBS) who need additional nutrition from intravenous feeding ... Continue Reading ››
Will Off-Label Promotions Be Legal?
12.11.2012 | No Comments ››By now, you’ve probably heard of the case of Alfred Caronia, whose conviction of off-label promotion of Xyrem back in 2008 was overturned in early ... Continue Reading ››
The Digital Waiting Room: Call for a Patient Manifesto
06.15.2011 | No Comments ››Patient advocate Jeanne Barnett makes an impassioned plea for mercy after being held captive for hours in physicians' offices, and lays out her vision for ... Continue Reading ››
Pri-Med Point of Care Marketing Chief to Speak at DTC Perspectives Conference
03.24.2011 | Comments OffTom Richards, Senior Director of Marketing for Pri-Med Point of Care, has been selected as a speaker for the upcoming DTC National Conference workshop on ... Continue Reading ››
Pri-Med Access: A Bright Solution to Meeting Sunshine Act Requirements
12.03.2010 | No Comments ››Life science companies are scrambling to assimilate and execute the complex reporting requirements and compliance issues required of them by new and existing regulations, including ... Continue Reading ››
Patients Shun Pharma Sites for Medical Information
11.22.2010 | No Comments ››Sixty-eight percent of U.S consumers check online for health information, but only 11% consult a pharmaceutical company’s website for information about ... Continue Reading ››